Example Output: Empirical + Design Science Paper
================================================

This is an example of what the paper-architecture skill generates for a
paper with both measurement artifact and empirical contributions.

Source: Physician personality and opioid overprescription study


Session 1: Paper Architecture Overview (2026-02-07 15:45)
==========================================================

Location: Generated from @1-paper-structure-v0205-positive.md
Status: ✅ Auto-detected configuration

Auto-Detected Configuration:
┌─────────────────────────────────────────────────────────┐
│ Paper Type: Empirical + Artifact (Hybrid)               │
│ Target Venue: MISQ                                      │
│ Contributions Detected: 3                               │
│   - C1: Measurement Artifact (Primary, 40%)             │
│   - C2: Empirical Associations (Primary, 40%)           │
│   - C3: Causal Evidence (Tertiary, 20%)                 │
│ Strategic Constraints:                                  │
│   - downplay_causality (detected from "supplementary",  │
│     "suggestive", "2/4 outcomes significant")           │
│   - emphasize_measurement_innovation (detected from     │
│     "design principles", "validated artifact")          │
│   - acknowledge_incomplete_evidence (detected from "IV  │
│     incomplete", "missing first-stage diagnostics")     │
│ Key Metrics Extracted:                                  │
│   - Sample: 226,146 physicians, 24.7M prescriptions     │
│   - Validation: Cohen's kappa 0.85-0.89                 │
│   - Findings: 8/8 positive associations (100%)          │
│   - Subsample: 4-5x amplification (low back pain)       │
│   - IV: 2/4 outcomes significant (MME Total***, MME≥500***)│
└─────────────────────────────────────────────────────────┘


OVERALL CONTRIBUTION: One-Paragraph Summary
============================================

We develop a scalable LLM-based artifact that infers physician personality
from 3.6M patient reviews (226K physicians) and links to 24.7M prescriptions.
Four design principles enable observer-based measurement overcoming self-report
bias. We find systematic positive associations between agreeableness and opioid
overprescription across all 8 outcome specifications (main + subsample), with
4-5x amplification in homogeneous patient contexts. Supplementary IV analysis
(county-level peer norms) shows significant positive effects for 2/4 primary
outcomes, providing suggestive causal evidence. Results demonstrate measurement
innovation as theory-enabling technology and highlight accommodation mechanism:
agreeable physicians prioritize short-term satisfaction over long-term patient
welfare when incentives misalign.


KEY DATA POINTS
===============

**Scale:**
- 226,146 physicians with personality scores
- 3.6M patient reviews (avg 16 per physician)
- 24.7M prescriptions, 2.9M patients (2015-2019)
- Cost: ~$0.10 per physician (Gemini 2.5 Flash)

**Validation:**
- Cohen's kappa: 0.85-0.89 (inter-rater agreement)
- Human-LLM correlation: 0.72-0.89 (expert alignment)
- Behavioral prediction: r=0.41-0.81 with satisfaction

**Core Findings:**
- 8/8 positive associations (100% directional consistency)
- 7/8 statistically significant (p<0.05)
- 4-5x amplification in low back pain subsample
- IV significant for 2/4 outcomes (MME Total: 114x larger; MME≥500: 16x larger)


THREE MAIN CONTRIBUTIONS
=========================

**C1: Scalable Measurement Artifact (Primary, 40%)**
- Observer-text LLM inference at national scale (226K physicians)
- Four design principles: observer-text, aggregation, transparency, cross-validation
- Overcomes self-report bias + sample size + outcome linkage barriers
- Validated: kappa 0.85-0.89, human correlation 0.72-0.89
- Generalizable template for organizational behavior research

**C2: Systematic Empirical Evidence (Primary, 40%)**
- Agreeableness → overprescription: all 8 outcomes positive
- Robust to controls (physician, patient, prescription characteristics)
- Apple-to-apple comparison: 4-5x amplification in low back pain
- Accommodation mechanism: conflict avoidance + satisfaction incentives
- Consistency across volume and binary threshold definitions

**C3: Supplementary Causal Evidence (Tertiary, 20%)**
- County-level IV: 2/4 outcomes significant (MME Total***, MME≥500***)
- All 4 IV estimates positive (directional consistency)
- Suggestive of causal relationship, not definitive
- Follows methodological precedent from prior IV studies
- Measurement error correction story (16-114x amplification)


THEORETICAL IMPLICATIONS
=========================

**T1: Personality in High-Stakes Professional Decisions**
- Agreeableness systematically shapes consequential behaviors (addiction risk)
- Prosocial trait produces harmful outcomes when incentives misalign
- Person-situation interaction: trait effects amplified by satisfaction metrics

**T2: Accommodation as Vulnerability Mechanism**
- Conflict avoidance: immediate harmony prioritized over long-term welfare
- Temporal discounting: satisfaction benefits visible, addiction risks distant
- Incentive amplification: CMS 30% MIPS weight magnifies natural tendencies

**T3: Measurement Innovation Enables Theory Testing**
- LLM artifact expands testable theory scope (scale + ecological validity)
- Observer-based measurement overcomes self-presentation bias
- Administrative linkage validates traits against actual behaviors


POLICY IMPLICATIONS
===================

**P1: Risk Screening at Scale**
- Identify agreeable physicians at elevated risk before patterns emerge
- Scalable to 1M+ US physicians continuously (~$0.10 per physician)
- Dynamic risk assessment unlike one-time surveys

**P2: Personality-Tailored Interventions**
- Agreeable physicians: assertive communication training, peer feedback
- Different approaches for disagreeable physicians (outcome feedback, financial incentives)
- One-size-fits-all interventions miss targeting opportunity

**P3: Rethink Quality Metrics**
- Uniform satisfaction weighting (30% MIPS) may backfire for agreeable physicians
- Personality-contingent adjustments or conditional satisfaction measurement
- Precedent: other metrics adjusted for patient case mix

**P4: Practice Environment Design**
- Match personality to settings (group practice with oversight vs autonomous clinic)
- High-risk placements: autonomous pain clinics, emergency departments, FFS+bonus
- Protective placements: salaried group practices, structured protocol specialties


STORYTELLING ARC
================

**Act 1: Problem & Gap**
┌─────────────────────────────────────────────────────────┐
│ Opioid epidemic kills 500K+; physician variation critical│
│ Traditional personality research: self-report bias, small N│
│ Missing: scalable measurement + consequential outcomes  │
└─────────────────────────────────────────────────────────┘

**Act 2: Innovation**
┌─────────────────────────────────────────────────────────┐
│ LLM-based artifact from 3.6M patient reviews            │
│ Four design principles (observer-text, aggregation, etc.)│
│ Link to 24.7M prescriptions → consequential behaviors   │
│ Validation: kappa 0.85-0.89, human correlation 0.72-0.89│
└─────────────────────────────────────────────────────────┘

**Act 3: Discovery**
┌─────────────────────────────────────────────────────────┐
│ All 8 associations positive (100% directional consistency)│
│ Low back pain: 4-5x amplification (apple-to-apple)      │
│ IV supplementary evidence: 2/4 significant (suggestive) │
└─────────────────────────────────────────────────────────┘

**Act 4: Mechanism**
┌─────────────────────────────────────────────────────────┐
│ Accommodation mechanism: conflict avoidance + temporal  │
│ discounting + incentive amplification (30% MIPS)        │
│ Misaligned incentives turn prosocial trait harmful      │
└─────────────────────────────────────────────────────────┘

**Act 5: Impact**
┌─────────────────────────────────────────────────────────┐
│ Theory: Measurement innovation enables new theory tests │
│ Policy: Risk screening, tailored interventions, metric fixes│
│ Future: Generalizable template for organizational behavior│
└─────────────────────────────────────────────────────────┘


NARRATIVE STRATEGY
==================

**Primary Story (80% emphasis):**
"Scalable measurement innovation reveals systematic associations between
agreeableness and overprescription across all outcome definitions"

**Supporting Evidence (20% emphasis):**
"Supplementary IV analysis offers suggestive causal evidence for primary outcomes"

**Language to Use:**
- ✅ "Supplementary IV analysis provides supportive evidence..."
- ✅ "Systematic associations across all 8 outcome specifications..."
- ✅ "Suggestive causal evidence consistent with accommodation mechanism..."
- ✅ "Following methodological precedent from [cite similar IV studies]..."
- ✅ "Directional consistency strengthens confidence in systematic patterns..."

**Language to Avoid:**
- ❌ "We prove causality" or "definitively establish"
- ❌ "IV analysis demonstrates causal effects"
- ❌ "Agreeableness causes overprescription"
- ❌ "41% bias correction" (doesn't exist with 2/4 outcomes)
- ❌ "Complete causal validation"


SCOPE & BOUNDARIES
==================

What We Deliver
---------------
- Measurement artifact: LLM-based personality inference validated at national scale
  (kappa 0.85-0.89, N=226K physicians)
- Systematic associations: 8/8 positive outcomes across main + subsample analyses,
  7/8 p<0.05, 100% directional consistency
- Accommodation mechanism framework: theoretical integration of personality psychology +
  agency theory + healthcare incentive systems
- Low back pain robustness: 4-5x amplification in homogeneous patient context
  (apple-to-apple comparison)
- Supplementary IV evidence: county-level peer agreeableness analysis, 2/4 outcomes
  significant (MME Total***, MME≥500***), directional consistency across all 4

What Is Out of Scope
---------------------
- Definitive causal claims: IV evidence incomplete (2/4 outcomes significant,
  Daily MME≥90 and High Dosage not significant)
- Other Big Five traits: conscientiousness, neuroticism, openness, extraversion
  not tested (agreeableness focus only)
- Heterogeneity analysis by specialty: primary care vs specialist effects not
  examined (H3a not tested)
- Heterogeneity analysis by pain type: acute vs chronic pain moderation not
  examined (H3b not tested)
- Heterogeneity by compensation structure: fee-for-service vs salaried effects
  not examined (H3c not tested)
- Placebo outcomes: NSAIDs, statins, metformin, antibiotics not tested
  (exclusion restriction validation absent)
- Non-Medicare populations: commercial insurance, Medicaid, uninsured patients
  not included (generalizability question)
- Experimental validation: randomized controlled trials of personality-contingent
  interventions not conducted

Limitations vs Design Choices
------------------------------

**Acknowledged Limitations:**
- IV evidence incomplete: 2/4 outcomes significant; Daily MME≥90 (β=0.0474, NS)
  and High Dosage (β=0.1081, NS) not significant despite positive point estimates
- First-stage diagnostics missing: F-statistic, Hausman test, Cragg-Donald
  statistics, weak instrument tests to be computed before submission (critical gap)
- Review-based measurement noise: contains observer idiosyncrasies and limited
  reviews per physician (avg 16); reliability ~70-80% vs gold-standard NEO-PI-R
- Medicare-only sample: limited to patients age 65+, disabled, ESRD;
  generalizability to younger populations and non-Medicare contexts uncertain
- Zipcode IV fails: exclusion restriction likely violated (3/4 negative estimates,
  peer spillovers); county-level used instead

**Intentional Design Choices:**
- Focus on agreeableness: highest LLM validation metrics (kappa 0.89 vs 0.75-0.82
  for other traits), clearest theoretical mechanism (accommodation pathway)
- Observational emphasis: measurement innovation (40%) + systematic associations (40%)
  as primary contributions; IV results (20%) positioned as supplementary
- County-level IV preferred: better satisfies exclusion restriction vs zipcode-level
  (fewer peer spillovers, less direct consultation)
- Volume outcomes prioritized: MME Total and MME≥500 most robust in IV analysis;
  binary thresholds (Daily MME≥90, High Dosage) treated as exploratory
- CMS data 2015-2019: pre-COVID stable period with mature review platforms and
  established satisfaction incentives (CMS MIPS)

**Rationale:** Consistent with Primary/Secondary/Tertiary contribution structure
(40%/40%/20%), we position measurement artifact and systematic associations as
core deliverables, with IV results providing supportive evidence rather than
definitive proof. This aligns with evidence strength and MISQ design science
+ empirical priorities.

Future Work Prioritization
---------------------------

**High Priority** (required to strengthen current claims):
- First-stage diagnostics: compute F-statistic (test instrument relevance),
  Hausman test (validate IV necessity), Cragg-Donald and Stock-Yogo weak
  instrument diagnostics for TABLE 7
- Explain IV outcome inconsistency: why MME Total and MME≥500 significant but
  Daily MME≥90 and High Dosage not? Differential instrument strength analysis
- Placebo outcomes: test county-level peer agreeableness IV on NSAIDs, statins,
  metformin, antibiotics (should be null, validates exclusion restriction)
- Heterogeneity by specialty: subgroup IV analysis for primary care vs specialists
  (tests discretion hypothesis H3a, validates accommodation mechanism pathway)

**Medium Priority** (extend scope to new contexts):
- Other Big Five traits: conscientiousness (guideline adherence hypothesis),
  neuroticism (risk aversion hypothesis), openness (alternative treatment exploration)
- Non-Medicare populations: replicate with MarketScan (commercial insurance,
  age 18-64), Medicaid data (dual eligibles, low-income)
- Heterogeneity by pain type: acute vs chronic pain interaction (tests request
  intensity hypothesis H3b using ICD-10 classification)
- Temporal dynamics: early vs mid vs late career effects; response to regulatory
  changes (PDMP implementation, CDC guideline updates 2016/2022)

**Low Priority** (aspirational, long-term research agenda):
- Experimental validation: field RCT of personality-contingent interventions
  (assertiveness training for agreeable physicians) vs control
- Multi-modal behavioral phenotyping: combine LLM-inferred traits with prescribing
  patterns, EHR usage logs, patient portal communication style
- Real-time decision support: integrate personality scores into EHR-based clinical
  decision systems with personalized prompts at point of care
- Generalize artifact to other professions: teachers (student evaluations),
  lawyers (client reviews), executives (360-degree feedback, board evaluations)


PAPER POSITIONING FOR MISQ
===========================

**Primary Contribution:** Design Science Artifact (40%)
- Generalizable framework: four design principles for LLM-based behavioral measurement
- Rigorous validation: multi-model agreement, human expert benchmarking, behavioral prediction
- Unique value: overcomes three barriers (self-report bias, scale, outcome linkage) simultaneously
- MISQ fit: exemplifies IS artifact enabling theory testing at scale

**Secondary Contribution:** Systematic Empirical Evidence (40%)
- Largest personality-behavior study in healthcare (226K physicians, 24.7M prescriptions)
- Robust associations: 8/8 positive outcomes, comprehensive controls, multiple definitions
- Accommodation mechanism framework: integrates personality + agency theory + incentives
- MISQ fit: rigorous empirical evidence with theoretical grounding and practical relevance

**Tertiary Contribution:** Supplementary Causal Analysis (20%)
- County-level IV analysis: 2/4 outcomes significant, directional consistency
- Suggestive causal evidence, not definitive (acknowledges incomplete validation)
- Demonstrates methodological potential of artifact for sophisticated causal identification
- MISQ fit: innovative method application with honest assessment of limitations

**Rationale for Emphasis Distribution:**
Measurement artifact (40%) and systematic associations (40%) constitute primary story
because evidence is complete, robust, and novel. IV analysis (20%) positioned as
supplementary because evidence incomplete (2/4 outcomes, missing first-stage diagnostics)
but directionally supportive. This positioning aligns with MISQ priorities: design
science innovation + rigorous empirical evidence + honest acknowledgment of limitations.


===================================================================

End of Architecture Overview

> JL: [Space for user refinement comments]
>> CC: [Skill responses to refinements appear here]
